The Immune/Inflammatory Pipeline: A Strategic Review

Table of Contents

• Executive Summary
  • Strategic Considerations
  • Stakeholder Implications
• Introduction
• The Immune/Inflammatory Disease Pipeline
  • Emerging Agents Targeting Diseases with Unmet Needs
  • Companies Developing Immune/Inflammatory Disease Agents
    • Current Market-Leading Companies
    • Novartis
    • GlaxoSmithKline
    • Pfizer
• Challenges and Opportunities in the Immune/Inflammatory Disease Market.
  • Current Market-Leading Products Pose a High Hurdle for Emerging Therapies......
  • ......But Also Leave Gaps That Provide Opportunities for Emerging Agents
    • Opportunities in Rheumatoid Arthritis.
    • Opportunities in Chronic Obstructive Pulmonary Disease
    • Opportunities in Systemic Lupus Erythematosus.
• Outlook for Emerging Agents
  • Current Market Statistics
  • Pipelines and Companies
  • Will Mergers & Acquisitions Continue to Move the Market?
  • Will Market-Leading Companies Continue to Dominate?

Tables

• 1. Descriptions of Inflammatory and Autoimmune Disorders
• 2. Drug Classes Commonly Used to Treat Cardiovascular Diseases
• 3. Key Unmet Needs in Common Immune/Inflammatory Diseases
• 4. Immune/Inflammatory Market-Leading Companies, 2008
• 5. Top-Selling Immune/Inflammatory Drugs, 2008
• 6. Novartis' s Immune/Inflammatory Pipeline
• 7. GlaxoSmithKline' s Immune/Inflammatory Pipeline
• 8. Pfizer' s Immune/Inflammatory Pipeline
• 9. Wyeth' s Immune/Inflammatory Pipeline

Figures

• 1. Percentage of Novel and Non-Novel Molecules in the Immune/Inflammatory Pipeline
• 2. Immune/Inflammatory Pipeline by Development Phase
• 3. Immune/Inflammatory Pipeline by Disease
• 4. Percentage of Immune/Inflammatory Pipeline Drugs by Type
• 5. Drugs Targets, by Number, of Immune/Inflammatory Pipeline Drugs
• 6. Development Activity by Company Size
• 7. Companies with Multiple Immune/Inflammatory Drugs in Development
• 8. Companies with Leading Immune/Inflammatory Pipelines, Number of Agents by Disease
• 9. GlaxoSmithKline' s Immune/Inflammatory Franchise Sales, 2008
• 10. Abbott Laboratories' Immune/Inflammatory Franchise Sales, 2008
• 11. Immune/Inflammatory Sales by Therapy Area, 2003-2008
• 12. Immune/Inflammatory Disease Market Growth by Region, 2003-2008.
• 13. Worldwide Sales of Immune/Inflammatory Drug Classes, 2008